Similar Search Results

The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention : the case of general colorecta...

Tscheulin, Dieter K.; Drevs, Florian - In: The European journal of health economics : HEPAC ; … 11 (2010) 2, pp. 141-150

Persistent link: https://www.econbiz.de/10003948354

On the welfare theoretic foundation of cost-effectiveness analysis : the case when survival is not affected

Liljas, Bengt - In: The European journal of health economics : HEPAC ; … 11 (2010) 1, pp. 5-13

Persistent link: https://www.econbiz.de/10003942635

Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients : a two-year prospective c...

Hamre, Harald J.; Witt, Claudia M.; Glockmann, Anja; … - In: The European journal of health economics : HEPAC ; … 11 (2010) 1, pp. 77-94

Persistent link: https://www.econbiz.de/10003942711

Economic valuation and determinants of informal care to people with Alzheimer’s disease

Peña-Longobardo, Luz María; Oliva, Juan - In: The European journal of health economics : HEPAC ; … 16 (2015) 5, pp. 507-515

Persistent link: https://www.econbiz.de/10011299216

Costs and benefits of home care for the elderly versus residential care : a comparison using propensity scores

Kok, Lucy; Berden, Caroline; Sadiraj, Klarita - In: The European journal of health economics : HEPAC ; … 16 (2015) 2, pp. 119-131

Persistent link: https://www.econbiz.de/10011299560

Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand

Yamwong, Sukit; Unchalee Permsuwan; Tinmanee, Sirana - In: Health economics review 4 (2014) 17, pp. 1-7

Objectives: To evaluate the long-term cost-effectiveness of ticagrelor and ASA versus generic and branded clopidogrel and ASA in patients with ACS based on a Thai cost database. Methods: A one-year decision tree and a long-term Markov model were constructed to estimate lifetime costs and...

Persistent link: https://www.econbiz.de/10010526870

Cost-utility analysis of case management for frail older people : effects of a randomised controlled trial

Sandberg, Magnus; Jakobsson, Ulf; Midlöv, Patrik; … - In: Health economics review 5 (2015) 12, pp. 1-13

Background: To evaluate the effects of a case management intervention for frail older people (aged 65+ years) by cost and utility. Materials and methods: One hundred and fifty-three frail older people living at home were randomly assigned to either an intervention (n = 80) or a control group (n...

Persistent link: https://www.econbiz.de/10010528669

Orphan drugs policies : a suitable case for treatment ; editorial

Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 335-340

Persistent link: https://www.econbiz.de/10010360871

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

Samyshkin, Yevgeniy; Kotchie, Robert W.; Mörk, Ann-Christin - In: The European journal of health economics : HEPAC ; … 15 (2014) 1, pp. 69-82

Persistent link: https://www.econbiz.de/10010235895

Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain

Hidalgo Vega, Alvaro; Ramos-Goñi, Juan Manuel; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 9, pp. 917-925

Persistent link: https://www.econbiz.de/10010478210